Clinical Trial Results

Showing: All studies [change]
Condition: Breast Cancer Location: Laconia, New Hampshire 8 trials found
New Search
Filter
Trial Phase
Study Type
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
PHASE1INTERVENTIONAL Norwalk, Connecticut +4 more
RECRUITING
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
NAINTERVENTIONAL Lebanon, New Hampshire
RECRUITING
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
PHASE1INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients
PHASE2INTERVENTIONAL Lebanon, New Hampshire
RECRUITING
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
PHASE3INTERVENTIONAL Hot Springs, Arkansas +4 more
RECRUITING
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.
PHASE4INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type